Investor Relations

Regulatory News Announcements (RNS)

Search RNS News:
Unaudited Preliminary Results

RNS Number : 6044G Advanced Medical Solutions Grp PLC 13 March 2024   Full Year 2023 Trading Update ~ AMS set for strong growth in 2024, underpinned by implementation of commercial initiatives, product launches, as well as a transformational surgical acquisition...

read more
Proposed Acquisition Of Peters Surgical

RNS Number : 6047G Advanced Medical Solutions Grp PLC 13 March 2024   Proposed acquisition of Peters Surgical   ~ Transformational acquisition of Peters Surgical strengthens AMS's position as a leading global specialist in tissue repair and skin closure ~ ~...

read more
Block Listing Interim Review

RNS Number : 4271G Advanced Medical Solutions Grp PLC 12 March 2024   Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the world-leading specialist in tissue-healing technologies, makes the following notification pursuant to Schedule Six of the AIM...

read more
Full Year Trading Update

RNS Number : 1554Z Advanced Medical Solutions Grp PLC 10 January 2024 Full Year 2023 Trading Update In line with expectations for FY 2023 and poised for strong growth in 2024 Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the world-leading specialist...

read more
Total Voting Rights

RNS Number : 2873V Advanced Medical Solutions Grp PLC 30 November 2023 Total Voting Rights In accordance with Disclosure and Transparency Rule 5.6.1, the issued share capital of Advanced Medical Solutions Group plc as at 30 November 2023 comprises 217,328,664 ordinary...

read more
Total Voting Rights

RNS Number : 9222R Advanced Medical Solutions Grp PLC 31 October 2023 Total Voting Rights In accordance with Disclosure and Transparency Rule 5.6.1, the issued share capital of Advanced Medical Solutions Group plc as at 31 October 2023 comprises 217,296,349 ordinary...

read more
US LiquiBand® distribution agreements signed

RNS Number : 1585R Advanced Medical Solutions Grp PLC 25 October 2023 All new US LiquiBand® hospital distribution agreements signed New US route-to-market strategy now operational and expected to accelerate the growth of LiquiBand® in the US from Q4 2023 Winsford, UK:...

read more